$7.55 Million Settlement over a False Claims Act Allegations Against Galena Biopharma Inc Announced by Whistleblower Institute
The Whistleblower Institute announces that Galena Biopharma Inc reached a $7.55 million settlement in a whistleblower lawsuit over paying kickbacks to doctors to induce them to prescribe its fentanyl-based drug Abstral.
View full press release